Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients.

Show more authors
+ 1
Maarten J Deenen
Annemieke Cats
Jos H Beijnen
Jan H M Schellens

More about this publication

Therapeutic advances in medical oncology

Volume 5
Issue nr. 1
Pages 91-2
Publication date 01-01-2013

Full text links

Publisher website (DOI) 10.1177/1758834012464806
Europe PubMed Central 23323150
Pubmed 23323150

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.